The use of nonsteroidal anti-inflammatory drugs and the occurrence of gastric lesions among patients undergoing upper endoscopy in a university hospital in Brazil

Clinics

Volumn 61, Issue 5, 2006, Pages 409-416

  Ribeiro, Andreia Queiroz ^a   Sevalho, Gil ^a   César, Cibele Comini ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Adverse drug reaction; Nonsteroidal anti inflammatory drugs; Pharmacoepidemiology; Upper endoscopy

Indexed keywords

EID: 33750398363     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322006000500007     Document Type: Article

References (33)

1. Barrier CH, Hirschowitz BI. Controversies in the detection and management of nonsteroidal antiinflammatory drug-induced side effects of the upper gastrointestinal tract. Arthritis and Rheum. 1989;327:926-32.
2. Laporte JR, Ibanez L, Vidal X , Vendrell L, Leone R. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Saf. 2004;276:411-20.
3. Juntti-Patinen L, Neuvonen PJ. Drug-related deaths in a university central hospital. Eur J Clin Pharmacol. 2002;58:479-82.
4. Scarpignato C, Bjarnason I, Bretagne JF, De Pouvourville G, Garcia Rodriguez LA, et al. Towards a safer gastrointestinal antiinflammatory therapy. Gastroenterol Int. 1999;12:186-215.
5. Peura, DA. Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications. Am J Med. 2004;117 (Suppl. 5A):63S-71S.
6. BiancarelliI A, Lambert P. Benefício de genérico pode demorar 2 anos. Folha São Paulo, São Paulo, 20 fev. 2000.
7. Béria JU, Victora CG, Barros FC, Teixeira AB, Lombardi C. Epidemiologia do consumo de medicamentos em crianças no centro urbano da região sul do Brasil. Rev Saúde Publica 1993;27:95-104.
8. Pepe VLE. Estudo sobre a prescrição de medicamentos em uma Unidade de Atenção Primária. 1994. 210 p. Dissertação (Mestrado em Saúde Coletiva) - Instituto de Medicina Social, Universidade Estadual do Rio de Janeiro, Rio de Janeiro.
9. Vilarino JF, Soares IC, Silveira CM, Rodel AP, Bortoli R, Lemos RR. Perfil da automedicação em município do sul do Brasil. Rev Saúde Publica 1998;32:43-49.
10. Mosegui GBG, Rozenfeld S, Veras RP, Vianna CMM. Avaliação da qualidade do uso de medicamentos em idosos. Rev Saude Publica 1999;33:437-44.
11. Dainesi, SM. Pharmacovigilance: More than ever, an overall responsibility. Clinics. 2005; 60:267-270.
12. Anacleto TA, Perini E, Rosa MB, César CC. Medication errors and drug-dispensing systems in the hospital pharmacy. Clinics. 2005; 60(4):257-325-332
13. Antonov K, Isacson D. Use of analgesics in Sweden - the importance of sociodemographic factors, physical fitness, health and health-related factors, and working conditions. Soc Sci Med. 1996;42:1473-81.
14. Hogan DB, Campbell NRC, Crutcher R, MacLeoad N. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta. Can Med Assoc J. 1994;151:315-22.
15. Laporte JR, Carné X, Vidal X, Moreno V, Juan J. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Lancet. 1991;337:85-9.
16. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994;343:769-72.
17. Henry D, Dobson A, Turner C. Variability in the risk of major .gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology. 1993;105:1078-88.
18. Hernández-Diaz S, Garcia-Rodriguez LA. Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs. Excerpta Med. 2001;110 (Suppl.3A):20S-27S.
19. Úlcera gastroduodenal por antiinflamatorios no esteroides y su prevención. Butll groc. 1997;10:9-11.
20. Raskin JB. Gastrointestinal effects of nonsteroidal antiinflammatory therapy. Am J Med. 1999;106 (Suppl. 5B):3S-12S.
21. Cooper GS, Blades EW. Indications, contraindications and complications of upper gastrointestinal endoscopy. In Gastroenterologic endoscopy 2. ed. Sivak, MVJ, editor. Baltimore, Maryland: W.B. Saunders; 1999; CD-ROM. Produced by Corporate Technology Ventures.
22. Zaterka S. Lesões induzidas por AINE no sistema digestório. Rev Bras Med. 2000;57:882-900.
23. Agrawal NM, Roth S, Graham DY, White RH. Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial. Ann Intern Med. 1991;115:195-200.
24. Hawkey CJ, Naesdal J, Wilson I, Langstrom G, Swannel AJ, Peacock RA, Yeomans ND. Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs. Gut. 2002;51:336-43.
25. Taha AS, Sturrock RD, Russel RI. Mucosal erosions in longterm nonsteroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori. Gut. 1995;36:334-6.
26. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol. 1995;90:206-10.
27. Cheatun DE, Arvanitakis C, Gumpel M, Stead H, Geis GS. An .endoscopic study of gastroduodenal lesions induced by nonsteroidal anti- inflammatory drugs. Clin Ther. 1999;21:992-1003.
28. Voutilainen M, Mäntynen T, Färkkilä MJ, Sipponen P. Impact of nonsteroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease. Scand J Gastroenterol. 2001;36:817-21.
29. Klaukka T, Makela M, Sipila J., Martikainen J. Multiuse of medicines in Finland. Med Care. 1993;31:445-50.
30. Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scand J Prim Health Care. 2003;21:153-8.
31. Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1991;114:735-40.
32. Peura, DA. Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications. Am J Med. 2004;117 (Suppl. 5A):63S-71S.
33. Russel RI. Defining patients at risk of non-seteroidal anti-inflammatory drug gastropathy. Ital J Gastroenterol Hepatol. 1999;31 (Suppl 1):S14-S18.